Yoshifumi Ueda
Overview
Explore the profile of Yoshifumi Ueda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueda Y, Kiyonaka S, Selfors L, Inoue K, Harada H, Doura T, et al.
Nat Cell Biol
. 2025 Feb;
27(3):530-543.
PMID: 39984655
Intratumour heterogeneity represents the hierarchical integration of genetic, phenotypic and microenvironmental heterogeneity. Although single-cell sequencing has clarified genetic and phenotypic variability, the heterogeneity of nongenetic, microenvironmental factors remains elusive. Here,...
2.
Sakaguchi R, Takahashi N, Yoshida T, Ogawa N, Ueda Y, Hamano S, et al.
J Biol Chem
. 2024 Aug;
300(9):107705.
PMID: 39178948
The cell signaling molecules nitric oxide (NO) and Ca regulate diverse biological processes through their closely coordinated activities directed by signaling protein complexes. However, it remains unclear how dynamically the...
3.
Miki K, Oe M, Suzuki K, Miki K, Mu H, Kato Y, et al.
J Mater Chem B
. 2024 Jun;
12(28):6959-6967.
PMID: 38913327
Aldehyde dehydrogenase 1A1 (ALDH1A1) stands out as one of the most reliable intracellular biomarkers for stem cells because it is expressed in both cancer stem cells (CSCs) and normal somatic...
4.
Kohashi H, Nagata R, Tamenori Y, Amatani T, Ueda Y, Mori Y, et al.
Nucleic Acids Res
. 2024 Apr;
52(9):4784-4798.
PMID: 38621757
Antisense oligonucleotide (ASO) therapy is a novel therapeutic approach in which ASO specifically binds target mRNA, resulting in mRNA degradation; however, cellular uptake of ASOs remains critically low, warranting improvement....
5.
Oe M, Miki K, Ueda Y, Mori Y, Okamoto A, Funakoshi Y, et al.
ACS Sens
. 2021 Aug;
6(9):3320-3329.
PMID: 34445866
Accumulating evidence supports that cancer stem cells (CSCs) are responsible for cancer proliferation, metastasis, and therapy resistance; therefore, an effective strategy to identify and isolate CSCs is required urgently. Because...
6.
Otake S, Otsubaki T, Uesato N, Ueda Y, Murayama T, Hayashi M
Biol Pharm Bull
. 2021 Jan;
44(4):528-534.
PMID: 33473072
Psoriasis is an immune disorder-related inflammatory skin disease. Recent studies have suggested a contribution of T cell activation in the pathogenesis of psoriasis. Interleukin-2 (IL-2)-inducible T cell kinase (ITK) regulates...
7.
Nurmamat M, Ishida Y, Yori R, Sumida K, Zhu S, Nakatake M, et al.
Sci Rep
. 2018 Jun;
8(1):9073.
PMID: 29899419
Transient electron-hole pairs generated in semiconductors can exhibit unconventional excitonic condensation. Anisotropy in the carrier mass is considered as the key to elongate the life time of the pairs, and...
8.
Wu S, Sumida K, Miyamoto K, Taguchi K, Yoshikawa T, Kimura A, et al.
Nat Commun
. 2017 Dec;
8(1):1919.
PMID: 29203768
Conventional Rashba spin polarization is caused by the combination of strong spin-orbit interaction and spatial inversion asymmetry. However, Rashba-Dresselhaus-type spin-split states are predicted in the centrosymmetric LaOBiS system by recent...
9.
Takada Y, Hirano M, Kiyonaka S, Ueda Y, Yamaguchi K, Nakahara K, et al.
Cell Calcium
. 2015 Jul;
58(3):296-306.
PMID: 26142343
Autism is a neurodevelopmental psychiatric disorder characterized by impaired reciprocal social interaction, disrupted communication, and restricted and stereotyped patterns of interests. Autism is known to have a strong genetic component....
10.
Takahashi N, Hamada-Nakahara S, Itoh Y, Takemura K, Shimada A, Ueda Y, et al.
Nat Commun
. 2014 Sep;
5:4994.
PMID: 25256292
Mutations in the ankyrin repeat domain (ARD) of TRPV4 are responsible for several channelopathies, including Charcot-Marie-Tooth disease type 2C and congenital distal and scapuloperoneal spinal muscular atrophy. However, the molecular...